International

The companies say this will be the 'world's first' in-clinic application of VR with psychedelic-assisted therapy

The initial shipment will be 1,000 units at the start of next year

The agreement is a 'watershed moment in advancing European energy security' according to the U.S. secretary of state

Promoting advanced nuclear energy will be one of the priorities established by the new agreement

Despite an economic downturn in many industries this year, clean energy continues to be an attractive investment

'It Matters To You' discusses the potential impact of the alternative energy source down under and around the globe

The nation is set to be the second in Europe to permit the use of recreational pot

The market researcher anticipates a 14.5% CAGR during the 2021-2026 forecast period

The new member organization consists of over 78,000 psychiatrists

The company believes it now owns the largest cannabis R&D cultivation site on the globe

Companies say addition of BLK MKT to IM's product portfolio will strengthen their relationship

Panaxia will manage manufacturing with Neuraxpharm responsible for marketing and distribution

The three organizations will work with the CBD Training Academy to help revolutionize the Korean cannabis industry

Company claims its innovative patented tech will accelerate dissolution rates of distillate when administered orally

The firm has sent its product to different markets worldwide including Germany, Israel, Brazil, Mexico, Poland and now the Czech Republic

New retail outlet said to be first one located in a major transportation hub around the globe

A draft of the regulation will be presented in the upcoming months

Organization to supply GMP product for second major clinical trial down under this month

The company expects to start exporting early next year

New fund will support studies on psychedelic-assisted therapies for the treatment of mental health conditions

Chaves took over the presidency this April

Flagship product from company's medical cannabis division now set for clinical trial use

Tilray's products are now approved by the Polish Ministry of Health

Innovative new studies in the Middle East receive approval from Israeli Ministry of Health

Company revenue increased 49% year over year and 1% sequentially, but annual operational costs increased by 111%

Market anticipated to ascend in value by 250% into 2031

Vancouver conglomerate establishes foothold in European cannabis market

Publicly traded Canadian company wholly owns Efurt-based outfit and has 51% share of Hamburg CBD producer

New cannabinoid soft gel varieties from Irwin to be made available throughout Canada in the near future

Well-established Quebec cultivator enters into exclusive brand partnership with Exotic Genetix

Seattle-based firm now offering solutions to pot-related establishments throughout the United States

New inhalable drug containing CBD designed for efficacious treatment of brain injuries

The multinational also announced a couple of leadership updates

CBD producer initiates new customer savings initiative to promote cannabinoid access for the masses

The platform has been launched in Germany, France, the United Kingdom and Portugal

International cannabis concentrate sector anticipated to triple in value by 2030

Clinical psychedelic sector value anticipated to ascend significantly into 2028

The partnership was announced in March this year

Medical Marijuana, Inc. subsidiary now working to promote cannabis and CBD

In July last year, the company received a pharmaceutical Drug Establishment License from Health Canada